Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES STRIDES PHARMA SCIENCE ALKEM LABORATORIES/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 32.8 -48.1 - View Chart
P/BV x 4.3 1.3 328.8% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 ALKEM LABORATORIES   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
STRIDES PHARMA SCIENCE
Mar-22
ALKEM LABORATORIES/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs4,068947 429.6%   
Low Rs2,671305 877.2%   
Sales per share (Unadj.) Rs889.4341.9 260.1%  
Earnings per share (Unadj.) Rs140.5-40.5 -347.2%  
Cash flow per share (Unadj.) Rs166.0-14.5 -1,142.5%  
Dividends per share (Unadj.) Rs34.000-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs722.4262.5 275.2%  
Shares outstanding (eoy) m119.5789.79 133.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.81.8 207.0%   
Avg P/E ratio x24.0-15.5 -155.1%  
P/CF ratio (eoy) x20.3-43.1 -47.1%  
Price / Book Value ratio x4.72.4 195.7%  
Dividend payout %24.20-   
Avg Mkt Cap Rs m402,86856,177 717.1%   
No. of employees `000NANA-   
Total wages/salary Rs m19,6276,469 303.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,34230,703 346.4%  
Other income Rs m1,6271,320 123.2%   
Total revenues Rs m107,96832,022 337.2%   
Gross profit Rs m20,380-2,639 -772.2%  
Depreciation Rs m3,0402,330 130.4%   
Interest Rs m5241,767 29.6%   
Profit before tax Rs m18,443-5,417 -340.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,640-1,783 -92.0%   
Profit after tax Rs m16,803-3,634 -462.3%  
Gross profit margin %19.2-8.6 -222.9%  
Effective tax rate %8.932.9 27.0%   
Net profit margin %15.8-11.8 -133.5%  
BALANCE SHEET DATA
Current assets Rs m84,35433,618 250.9%   
Current liabilities Rs m48,05334,117 140.8%   
Net working cap to sales %34.1-1.6 -2,102.7%  
Current ratio x1.81.0 178.1%  
Inventory Days Days4292 45.6%  
Debtors Days Days65144 45.1%  
Net fixed assets Rs m43,24533,989 127.2%   
Share capital Rs m239898 26.6%   
"Free" reserves Rs m86,13422,670 379.9%   
Net worth Rs m86,37323,568 366.5%   
Long term debt Rs m948,356 1.1%   
Total assets Rs m127,59967,607 188.7%  
Interest coverage x36.2-2.1 -1,753.9%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.80.5 183.5%   
Return on assets %13.6-2.8 -491.7%  
Return on equity %19.5-15.4 -126.2%  
Return on capital %21.9-11.4 -191.9%  
Exports to sales %18.760.7 30.9%   
Imports to sales %00-   
Exports (fob) Rs m19,92418,639 106.9%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,92419,390 102.8%   
Fx outflow Rs m3,911529 739.5%   
Net fx Rs m16,01318,861 84.9%   
CASH FLOW
From Operations Rs m11,110-2,578 -430.9%  
From Investments Rs m-14,351-1,187 1,208.7%  
From Financial Activity Rs m3,7964,213 90.1%  
Net Cashflow Rs m580449 129.1%  

Share Holding

Indian Promoters % 57.2 30.8 185.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 20.2 36.9 54.7%  
FIIs % 4.5 21.4 20.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.8 68.9 62.2%  
Shareholders   79,721 130,682 61.0%  
Pledged promoter(s) holding % 0.0 70.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs STRIDES PHARMA SCIENCE Share Price Performance

Period ALKEM LABORATORIES STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 0.34% 5.29% 0.23%
1-Month -1.10% 12.39% 0.36%
1-Year -12.29% -31.49% -6.87%
3-Year CAGR 14.98% -4.49% 20.16%
5-Year CAGR 9.37% -16.21% 11.07%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.2% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 31.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

STRIDES PHARMA SCIENCE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.